Pricing Log in Create free account

ABVC BioPharma, Inc. (ABVC) vs Celyad SA (CYAD)

ABVC BioPharma, Inc. and Celyad SA are both Biotechnology companies. ABVC BioPharma, Inc. and Celyad SA are of similar size ($24.9M and $23.8M). Across the 11 metrics below, Celyad SA leads on 6 and ABVC BioPharma, Inc. on 5.

Valuation

Metric ABVC CYAD Biotechnology median
P/E n/m n/m 8.50
P/S 18.38 n/m 9.71
P/B 1.95 11.18 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m — 0.64
EV/Sales 19.64 — 9.21
Earnings yield (36.91%) (708.87%) (33.15%)
Free cash flow yield (11.33%) (438.06%) (25.50%)

Profitability

Metric ABVC CYAD Biotechnology median
Gross margin 99.97% 0.00% 65.16%
Operating margin 0.00% — 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (65.32%) 0.00% (56.36%)
Return on assets (39.88%) 0.00% (48.04%)
Return on invested capital (33.45%) 0.00% 0.00%

Growth

Metric ABVC CYAD Biotechnology median
Revenue growth (TTM) 5,035.43% — 6.02%
EPS growth (last fiscal year) 7.14% 113.33% 30.26%
Revenue growth, 5-year CAGR (6.20%) (63.51%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ABVC CYAD Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.07 0.94 4.72
Net debt to EBITDA 0.21 (1.62) 0.96

Dividend

Metric ABVC CYAD Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ABVC CYAD Biotechnology median
Market cap 24.89m 23.79m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack